Friday, 29 September 2017

Zogenix epilepsy drug meets main goal in late-stage trial

(Reuters) - Zogenix Inc said on Friday its experimental treatment for a rare form of epilepsy met the main goal in a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)